Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-25

Clinical Trial Update: AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Males With DMD

View source ↗

Summary

This clinical trial update describes the AFFINITY BEYOND study, an anti-AAV8 antibody assessment in males with Duchenne muscular dystrophy, which is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: REGENXBIO Inc. | Conditions: Duchenne Muscular Dystrophy | Status: RECRUITING